卓越新能(688196.SH)大股東卓越投資延長股份鎖定期
格隆匯12月22日丨卓越新能(688196.SH)發佈,公司控股股東龍巖卓越投資有限公司持有公司股份5,850萬股,佔公司股份比例48.75%,股票鎖定期延長6個月至2023年5月20日。
股東香港卓越國際控股有限公司持有公司股份3,150萬股,佔公司股份比例26.25%,股票鎖定期延長6個月至2023年5月20日。
經核查,保薦機構英大證券有限責任公司認為:公司大股東卓越投資、香港卓越及實際控制人延長股份鎖定期的行為不存在違反股份鎖定承諾的情形,不存在有損上市公司和全體股東特別是中小股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.